|
1
|
de Fost M, van Trotsenburg AS, van Santen
HM, Endert E, van den Elzen C, Kamsteeg EJ, Swaab DF and Fliers E:
Familial neurohypophyseal diabetes insipidus due to a novel
mutation in the arginine vasopressin-neurophysin II gene. Eur J
Endocrinol. 165:161–165. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kronenberg H and Williams RH: Williams
textbook of endocrinology. Saunders/Elsevier; Philadelphia, PA:
2008
|
|
3
|
Wesche D, Deen PM and Knoers NV:
Congenital nephrogenic diabetes insipidus: The current state of
affairs. Pediatr Nephrol. 27:2183–2204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee YW, Lee KW, Ryu JW, Mok JO, Ki CS,
Park HK, Kim YJ, Kim SJ, Byun DW, Suh KI, et al: Mutation of Glu78
of the AVP-NPII gene impairs neurophysin as a carrier protein for
arginine vasopressin in a family with neurohypophyseal diabetes
insipidus. Ann Clin Lab Sci. 38:12–14. 2008.PubMed/NCBI
|
|
5
|
Ye D, Dong F, Lu W, Zhang Z, Lu X, Li C
and Liu Y: A missense mutation in the arginine-vasopressin
neurophysin-II gene causes autosomal dominant neurohypophyseal
diabetes insipidus in a Chinese family. Clin Endocrinol (Oxf).
78:920–925. 2013. View Article : Google Scholar
|
|
6
|
Duzenli D, Saglar E, Deniz F, Azal O,
Erdem B and Mergen H: Mutations in the AVPR2, AVP-NPII, and AQP2
genes in Turkish patients with diabetes insipidus. Endocrine.
42:664–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu F, Jin Z and Zhang D: The etiology and
clinical characteristics of central diabetes insipidus, a
retrospective study of 408 cases. Zhonghua Yi Xue Za Zhi.
81:1166–1171. 2001.In Chinese.
|
|
8
|
Russell TA, Ito M, Ito M, Yu RN, Martinson
FA, Weiss J and Jameson JL: A murine model of autosomal dominant
neurohypophyseal diabetes insipidus reveals progressive loss of
vasopressin-producing neurons. J Clin Invest. 112:1697–1706. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brachet C, Birk J, Christophe C,
Tenoutasse S, Velkeniers B, Heinrichs C and Rutishauser J: Growth
retardation in untreated autosomal dominant familial
neurohypophyseal diabetes insipidus caused by one recurring and two
novel mutations in the vasopressin-neurophysin II gene. Eur J
Endocrinol. 164:179–187. 2011. View Article : Google Scholar
|
|
10
|
Fujisawa I: Magnetic resonance imaging of
the hypothalamic-neurohypophyseal system. J Neuroendocrinol.
16:297–302. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Babey M, Kopp P and Robertson GL: Familial
forms of diabetes insipidus: Clinical and molecular
characteristics. Nat Rev Endocrinol. 7:701–714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito M, Mori Y, Oiso Y and Saito H: A
single base substitution in the coding region for neurophysin II
associated with familial central diabetes insipidus. J Clin Invest.
87:725–728. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo Y, Wang B, Qiu Y, Zhang C, Jin C, Zhao
Y, Zhu Q and Ma X: Clinical and molecular analysis of a Chinese
family with autosomal dominant neurohypophyseal diabetes insipidus
associated with a novel missense mutation in the
vasopressin-neurophysin II gene. Endocrine. 42:208–213. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Christensen JH and Rittig S: Familial
neurohypophyseal diabetes insipidus - an update. Semin Nephrol.
26:209–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abu Libdeh A, Levy-Khademi F,
Abdulhadi-Atwan M, Bosin E, Korner M, White PC and Zangen DH:
Autosomal recessive familial neurohypophyseal diabetes insipidus:
Onset in early infancy. Eur J Endocrinol. 162:221–226. 2010.
View Article : Google Scholar
|
|
16
|
Rutishauser J, Böni-Schnetzler M, Böni J,
Wichmann W, Huisman T, Vallotton MB and Froesch ER: A novel point
mutation in the translation initiation codon of the
pre-pro-vasopressin-neurophysin II gene: Cosegregation with
morphological abnormalities and clinical symptoms in autosomal
dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol
Metab. 81:192–198. 1996.PubMed/NCBI
|
|
17
|
Beuret N, Rutishauser J, Bider MD and
Spiess M: Mechanism of endoplasmic reticulum retention of mutant
vasopressin precursor caused by a signal peptide truncation
associated with diabetes insipidus. J Biol Chem. 274:18965–18972.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Bree FM and Burbach JP:
Structure-function relationships of the vasopressin prohormone
domains. Cell Mol Neurobiol. 18:173–191. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Siggaard C, Rittig S, Corydon TJ,
Andreasen PH, Jensen TG, Andresen BS, Robertson GL, Gregersen N,
Bolund L and Pedersen EB: Clinical and molecular evidence of
abnormal processing and trafficking of the vasopressin
preprohormone in a large kindred with familial neurohypophyseal
diabetes insipidus due to a signal peptide mutation. J Clin
Endocrinol Metab. 84:2933–2941. 1999.PubMed/NCBI
|
|
20
|
Si-Hoe SL, De Bree FM, Nijenhuis M, Davies
JE, Howell LM, Tinley H, Waller SJ, Zeng Q, Zalm R, Sonnemans M, et
al: Endoplasmic reticulum derangement in hypothalamic neurons of
rats expressing a familial neurohypophyseal diabetes insipidus
mutant vasopressin transgene. FASEB J. 14:1680–1684.
2000.PubMed/NCBI
|
|
21
|
Arima H and Oiso Y: Mechanisms underlying
progressive polyuria in familial neurohypophysial diabetes
insipidus. J Neuroendocrinol. 22:754–757. 2010.PubMed/NCBI
|
